Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, ...
The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...
Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the ...
The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...
An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
A revolutionary advancement in cancer treatment at UH Seidman Cancer Center is dramatically reducing the time patients spend ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
Hydrogen peroxide creates a toxic environment for cancer cells. The jabs, given directly into the tumour, weaken the cells, ...
A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...